Back to Trades
Douglas Earl Martin
SVPGeneral CounselCIK 0001362155
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2026
Douglas Earl Martin, SVP, General Counsel, has filed 2 SEC reports (2026), all concentrated in Allogene Therapeutics, Inc. (ALLO), totaling $1.1M in disclosed volume. Weighing $0 bought versus $103.3K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Aug 25 | ALLO Allogene Therapeutics, Inc. | Douglas Earl Martin | SVP, General Counsel | Sell | $63.0K |
| Feb 4 | ALLO Allogene Therapeutics, Inc. | Douglas Earl Martin | SVP, General Counsel | Sell | $40.3K |
2 filings